Bicara Therapeutics Inc. announced the publication of updated interim data from its Phase 1/1b clinical trial of ficerafusp alfa combined with pembrolizumab for treating recurrent/metastatic head and ...

Good morning, and welcome to the Transgene conference call. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Transgene website following ...

A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has developed and validated an ...

Merus said Tuesday that the combination of its experimental drug petosemtamab with the checkpoint inhibitor Keytruda shrank tumors in 62% of patients with head and neck cancer, according to an interim ...

New research found patients with certain head and neck cancers lived longer and experienced fewer side effects when treated ...

Human papilloma virus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year. Unlike cervical ...

Head and neck cancers are often misunderstood as being limited to oral or mouth cancer. Head and neck cancer refers to a group of cancers that develop in the head and neck region, including the oral ...

The IAEA has launched a new two-year coordinated research project to explore how artificial intelligence can assist with contouring — a crucial step in cancer treatment, in which a tumour and the ...

Head and neck cancers affect the tissues of the mouth, throat, sinuses, and surrounding areas. They can impact crucial functions like breathing, swallowing, and talking. There are several types of ...

This guide for newly diagnosed patients provides key information to help you understand your options and have informed conversations with your oncologist. A diagnosis of head and neck cancer can bring ...